top of page
gradientForSurfBreak.png

Item List

Sep 25, 2024
Contract Pharma
Cytiva, Pear Bio Partner on Personalized Cancer Medicine

Cytiva, a global life sciences company, and Pear Bio, a pioneer in personalized cancer medicine, are collaborating to advance cancer research and personalized treatment. Pear Bio is using Cytiva’s Via Extractor technology to create dissociated tumor cell suspensions with high viability and yield, revolutionizing tumor cell analysis.

Recent Posts

Portfolio Company

Carlsmed.png

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Pr ...

Carlsmed

Feb 10, 2026

Portfolio Company

Carlsmed.png

xCures and the Colorectal Cancer Alliance Partner to Support Patient Access and ...

The National Law Review

Feb 5, 2026

Portfolio Company

Carlsmed.png

Vanguards of Health Care: Carlsmed Personalizes Spine with AI ...

Bloomberg

Feb 5, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page